Loxo Oncology Inc.
TREATMENT OF TRK-ASSOCIATED CANCERS

Abstract:

Provided herein are compounds and pharmaceutical compositions comprising the compounds and the use of the compounds in the treatment of cancer. More particularly, provided herein are method of treating cancer (e.g., a Trk-associated cancer) by administration of one or more Trk inhibitors and optionally an immunotherapy agent.